Home EVOTEC AG

EVOTEC AG

Evotec and Bayer Advance Endometriosis Program into Phase I Clinical Development and Extend Alliance

Evotec also announced today that both companies have agreed to extend this multi-target endometriosis alliance until the end of 2018.

EVOTEC EXPANDS IPSC DRUG DISCOVERY LEADERSHIP THROUGH STRATEGIC COLLABORATION WITH CENSO BIOTECHNOLOGIES

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a collaboration with Censo Biotechnologies Ltd....